EcoDrugPlus

Fibroblast Growth Factor Receptor 1

Ensembl ID : ENSOCUG00000004150
Gene Symbol: FGFR1
2 Cross references
289 Possible Orthologues:

Fibroblast Growth Factor Receptor 2

Ensembl ID : ENSOCUG00000007069
Gene Symbol: FGFR2
3 Cross references
216 Possible Orthologues:

Fibroblast Growth Factor Receptor 4

Ensembl ID : ENSOCUG00000003380
Gene Symbol: FGFR4
2 Cross references
123 Possible Orthologues:

Fms Related Receptor Tyrosine Kinase 1

Ensembl ID : ENSOCUG00000008523
Gene Symbol: FLT1
2 Cross references
198 Possible Orthologues:

Fms Related Receptor Tyrosine Kinase 3

Ensembl ID : ENSOCUG00000004897
Gene Symbol: FLT3
2 Cross references
133 Possible Orthologues:

Fms Related Receptor Tyrosine Kinase 4

Ensembl ID : ENSOCUG00000011092
Gene Symbol: FLT4
2 Cross references
195 Possible Orthologues:

Folate Hydrolase 1

Ensembl ID : ENSOCUG00000026120
Gene Symbol: FOLH1
2 Cross references
210 Possible Orthologues:

Follicle Stimulating Hormone Receptor

Ensembl ID : ENSOCUG00000011234
Gene Symbol: FSHR
2 Cross references
199 Possible Orthologues:

Free Fatty Acid Receptor 2

Ensembl ID : ENSOCUG00000017776
Gene Symbol: FFAR2
3 Cross references
331 Possible Orthologues:

Fyn Related Src Family Tyrosine Kinase

Ensembl ID : ENSOCUG00000001181
Gene Symbol: FRK
2 Cross references
216 Possible Orthologues:

Galectin 1

Ensembl ID : ENSOCUG00000024302
Gene Symbol: LGALS1
3 Cross references
380 Possible Orthologues:

Galectin 3

Ensembl ID : ENSOCUG00000002924
Gene Symbol: LGALS3
2 Cross references
218 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).